Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 7361 - 7368 of 12107 results
"Fallen Angel" Reverse Mergers Panel: An Alternative to the Traditional IPO
February 21, 2017| Blog| Viewpoint
Reexamination of "Healthy" Continues with an FDA Public Meeting in March 2017
February 20, 2017| Blog| Viewpoint
Update: DOL Regulation For Employers Who Use Direct Deposit and Payroll Debit Cards Invalidated
February 18, 2017| Blog| Viewpoint
The Future of the Affordable Care Act Week 6: Focus on the Individual Health Insurance Market
February 17, 2017| Blog| Viewpoint
FDA Hardens Its Stance on Intended Use and Off-Label Use and Industry Responds
February 17, 2017| Blog| Viewpoint
The Defend Trade Secrets Act: Securing Your Trade Secrets in 2017 LIVE Webcast
February 17, 2017| Blog| Viewpoint
US Patent Practice Drifting Toward Approach Prevalent Abroad
February 17, 2017| News
New York DOL Adopts Regulations Governing Employment Policies that Limit Employee Discussion of Wages
February 16, 2017| Blog| Viewpoint
News & Press Releases
Mintz Honored with NLADA Beacon of Justice Award
August 21, 2025
Mintz will receive a 2025 Beacon of Justice Award from the National Legal Aid & Defender Association (NLADA) for efforts to sustain equal justice for families and communities. This is the sixth consecutive year that Mintz has won this award.
SEC’s Pharmaceutical Insider Trading Case Yields Quick Deals
August 19, 2025
Bloomberg Law featured a statement from Member Jason P.W. Halperin in its coverage of a pharmaceutical insider trading case brought by the SEC. Jason and the Mintz team of Sean Prosser and Elizabeth Platonova represented Robert Yedid in reaching a resolution in which the client pled guilty and, along with the other defendants, entered into consent orders with the SEC.
Mintz Advises Oppenheimer & Co. and Initial Purchasers in $475M Convertible Senior Notes Offering by WisdomTree
August 19, 2025
Mintz represented Oppenheimer & Co., as sole book-running manager, and Craig-Hallum Capital Group and Northland Securities, as co-managers, in the private placement of $475 million aggregate principal amount of 4.625% Convertible Senior Notes due 2030 issued by WisdomTree, Inc (NYSE: WT) (“WisdomTree”). The notes were sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933.
Events
Podcasts
Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|